TY - JOUR
T1 - Trends in the Prevalence of Anogenital Warts among Patients at Sexually Transmitted Disease Clinics - Sexually Transmitted Disease Surveillance Network, United States, 2010-2016
AU - Mann, Laura M.
AU - Llata, Eloisa
AU - Flagg, Elaine W.
AU - Hong, Jaeyoung
AU - Asbel, Lenore
AU - Carlos-Henderson, Juli
AU - Kerani, Roxanne P.
AU - Kohn, Robert
AU - Pathela, Preeti
AU - Schumacher, Christina
AU - Torrone, Elizabeth A.
N1 - Publisher Copyright:
© 2018 Published by Oxford University Press for the Infectious Diseases Society of America 2018.
PY - 2019/4/16
Y1 - 2019/4/16
N2 - Background: Approximately 90% of genital warts are caused by human papillomavirus (HPV) types 6 and 11. In the United States, HPV vaccination has been recommended for girls and women aged ≤26 years, and since 2011, for boys and men aged ≤21 years and for gay, bisexual, and other men who have sex with men (MSM) aged ≤26 years. Methods: Data were obtained from 27 clinics participating in the STD Surveillance Network. Trends in the annual prevalence of anogenital warts (AGW) from 2010-2016 were described by sex and by the sex of sex partners. Results: During 2010-2016, significant declines in the prevalence of AGW were observed in women aged <40 years, men who have sex with women only (MSW) aged <40 years, and MSM of all age categories. An inflection in trend in 2012 was noted for MSW aged 20-24 or 25-29 years and for MSM aged 20-24 years. Conclusions: The observed declines in the prevalence of AGW suggest that HPV morbidity is declining among populations attending STD clinics, including MSW, MSM, and women. Declines in younger age groups are consistent with what would be expected following the implementation of HPV vaccination. However, declines were also observed in older age groups and are not likely to be the result of vaccination.
AB - Background: Approximately 90% of genital warts are caused by human papillomavirus (HPV) types 6 and 11. In the United States, HPV vaccination has been recommended for girls and women aged ≤26 years, and since 2011, for boys and men aged ≤21 years and for gay, bisexual, and other men who have sex with men (MSM) aged ≤26 years. Methods: Data were obtained from 27 clinics participating in the STD Surveillance Network. Trends in the annual prevalence of anogenital warts (AGW) from 2010-2016 were described by sex and by the sex of sex partners. Results: During 2010-2016, significant declines in the prevalence of AGW were observed in women aged <40 years, men who have sex with women only (MSW) aged <40 years, and MSM of all age categories. An inflection in trend in 2012 was noted for MSW aged 20-24 or 25-29 years and for MSM aged 20-24 years. Conclusions: The observed declines in the prevalence of AGW suggest that HPV morbidity is declining among populations attending STD clinics, including MSW, MSM, and women. Declines in younger age groups are consistent with what would be expected following the implementation of HPV vaccination. However, declines were also observed in older age groups and are not likely to be the result of vaccination.
KW - Anogenital warts
KW - genital warts
KW - human papillomavirus (HPV)
KW - sexually transmitted disease (STD)
KW - sexually transmitted infection (STI)
UR - http://www.scopus.com/inward/record.url?scp=85064987725&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064987725&partnerID=8YFLogxK
U2 - 10.1093/infdis/jiy684
DO - 10.1093/infdis/jiy684
M3 - Article
C2 - 30500908
AN - SCOPUS:85064987725
SN - 0022-1899
VL - 219
SP - 1389
EP - 1397
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - 9
M1 - jiy684
ER -